- Home >
- Life Sciences >
- Pharmaceutical >
Molecular Diagnostics: A Dynamic and Rapidly Broadening Market
Molecular Diagnostics: A Dynamic and Rapidly Broadening Market
- Report price : $ 2 995
- Publication date : January 2009
Molecular Diagnostics: A Dynamic and Rapidly Broadening Market
Molecular diagnostic applications in the areas of oncology, personalized medicine, inherited disorders, prediction of genetic disease risk, and many others are rapidly increasing in number as this burgeoning field expands beyond infectious disease testing. This report focuses on these newer applications of molecular diagnostics, analyzing:
- Established and up-and-coming technologies
- The activities of more than 35 companies
- More than 300 current and emerging molecular diagnostic tests for disease applications and genetic testing
- Business considerations associated with product development, commercialization, and marketing
- Regulatory issues
- Challenges facing companies developing molecular diagnostics and/or companion diagnostics and targeted therapies
- Major trends in the molecular diagnostics market, such as the increasing number of tests that are commercially available
RELATED REPORTS
Protease Inhibitors: Innovation Drives Drug Pipeline
- $ 2 995
- February 2009
Proteases constitute one of the largest potential drug target enzyme families, with 647 human gene products incorporating protease sequences and mutated proteases having been identified. In addition, there are many more proteases found in viruses, bacteria, and parasites, which are also potential d ...
Industries : Pharmaceutical
Direct-To-Consumer Genetic Testing: Business Prospects in the United States
- $ 2 995
- March 2009
The current marketplace for direct-to-consumer (DTC) genetic testing is very dynamic and fluid. At least 42 DTC genetic testing companies have been identified to date, and additional market entrants are likely. Firms marketing and selling genetic tests DTC have numerous factors to consider. This rep ...
Industries : Pharmaceutical
Medicinal Chemistry for Drug Discovery: Significance of Recent Trends
- $ 2 995
- March 2009
A thorough analysis of recent trends in medicinal chemistry and evaluation of their significance for advancing productivity in drug discovery is presented. This report includes:A critical evaluation of chemical and computational technological modalities, their current and potential value, and their ...
Industries : Pharmaceutical
Approaches to Reducing Phase II Attrition
- $ 2 995
- May 2009
Phase II is the critical development stage in which most clinical attrition occurs. This report focuses on approaches to improving R&D productivity in the pharmaceutical and biotechnology industries and considers:Leading-edge strategies being pursued to improve success rates of therapeutic candidate ...
Industries : Pharmaceutical
Bioinformatics and Computational Biology: Bottlenecks and Options
- $ 2 995
- June 2009
The interdisciplinary fields of Bioinformatics and Computational Biology are locked in a high stakes race with analytical instrument developers and innovators. The pace and scope of change in many fields of biomedical research rivals what we once associated only with semiconductor devices. This repo ...
Industries : Pharmaceutical
Conducting Clinical Trials in Europe: An Insider’s Analysis
- $ 2 995
- December 2008
A vast new opportunity for clinical trials has emerged in Europe as a result of the collapse of the Soviet Union and events during the last decade of the 20th century. The result is the emergence of dozens of sovereign countries and gone is the political dividing line between East and West Europe. N ...
Industries : Pharmaceutical
European Clinical Trial Site Options: An Insider's Analysis
- $ 2 995
- December 2008
A vast new opportunity for clinical trials has emerged in Europe as a result of the collapse of the Soviet Union and events during the last decade of the 20th century. The result is the emergence of dozens of sovereign countries and gone is the political dividing line between East and West Europe. N ...
Industries : Pharmaceutical
Neurodegenerative Diseases: Next-Generation Drugs for Four Major Disorders
- $ 2 995
- December 2008
Neurodegenerative diseases are drawing immense interest from the pharmaceutical industry and have inspired heavy competition in the race to introduce the next generation of improved drugs. Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral scle ...
Industries : Pharmaceutical
Biomedical Imaging: From Drug Target Discovery to Medical Diagnostics
- $ 2 995
- December 2008
Molecular imaging has become an increasingly indispensable tool in life sciences basic research, in translational medicine, and in routine medical diagnostics. This Biomedical Imaging report covers its top applications areas: medical diagnosis and translational research both relevant to pharmacology ...
Industries : Pharmaceutical
Stem Cells Come of Age
- $ 2 995
- November 2008
Commercialization of stem cells can potentially help to treat an astounding variety of medical conditions. After a slow start, the stem cell age is finally poised to begin, as numerous factors converge to catapult stem cell technology into the medical mainstream. This report considers:The current st ...
Industries : Pharmaceutical
Related industries
Related companies
reportlinker.com © Copyright 2009. All rights reserved